Kronos Bio, Inc. Proceeds from Stock Options Exercised
Kronos Bio, Inc. reported Proceeds from Stock Options Exercised of $1.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2025-03-18
- Kronos Bio, Inc. proceeds from stock options exercised for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Kronos Bio, Inc. proceeds from stock options exercised for the quarter ending 2024-09-30 was -$1.00K.
- Kronos Bio, Inc. proceeds from stock options exercised for the quarter ending 2023-12-31 was $1.00K.
- Kronos Bio, Inc. proceeds from stock options exercised for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Kronos Bio, Inc. proceeds from stock options exercised for fiscal 2024 was $1.00K, a 96.55% decline from fiscal 2023.
- Kronos Bio, Inc. proceeds from stock options exercised for fiscal 2023 was $29.00K, a 93.84% decline from fiscal 2022.
- Kronos Bio, Inc. proceeds from stock options exercised for fiscal 2022 was $471.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$1.00K derived: sum of 2 quarters · filed 2025-03-18 | $1.00K 10-K · filed 2025-03-18 | |
| 2024-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $1.00K 10-Q · filed 2024-11-13 | ||
| 2024-06-30 | $2.00K 10-Q · filed 2024-08-08 | |||
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $1.00K derived: sum of 2 quarters · filed 2025-03-18 | $29.00K derived: sum of 3 quarters · filed 2025-03-18 | $29.00K 10-K · filed 2025-03-18 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $28.00K derived: sum of 2 quarters · filed 2024-11-13 | $28.00K 10-Q · filed 2024-11-13 | -$1.03M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $28.00K 10-Q · filed 2024-08-08 | -$1.03M derived: sum of 3 quarters · filed 2024-08-08 | -$405.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | -$1.06M derived: sum of 2 quarters · filed 2024-03-21 | -$433.00K derived: sum of 3 quarters · filed 2024-03-21 | -$58.00K derived: sum of 4 quarters · filed 2024-03-21 |
| 2022-12-31 | -$1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$433.00K derived: sum of 2 quarters · filed 2024-03-21 | -$58.00K derived: sum of 3 quarters · filed 2024-03-21 | $471.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | $628.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.00M derived: sum of 2 quarters · filed 2023-11-13 | $1.53M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $375.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $904.00K 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $529.00K 10-Q · filed 2023-05-10 | |||
| 2021-09-30 | $1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.01M derived: sum of 2 quarters · filed 2022-11-08 | $2.60M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $627.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.22M 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $590.00K 10-Q · filed 2022-05-04 | |||
| 2020-09-30 | $278.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $411.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $133.00K 10-Q · filed 2021-08-12 |